Recent work also suggests that epigenetic regulation, including DNA methylation changes and alternative splicing of TTN, contributes significantly to disease progression in DCM patients [33], underscoring the importance of integrating genetic and epigenetic layers of regulation in TTN-mediated cardiomyopathy. This evidence concerns the gene TTN and cardiomyopathy.